2
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Myelodysplastic Syndromes
48
Multiple Myeloma
38
Lymphoma
37
Leukemia
35
Lymphoma, Non-Hodgkin
29
Leukemia, Lymphocytic, Chronic, B-Cell
24
Hodgkin Disease
24
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Hematologic Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
16
Primary Myelofibrosis
12
Neuroblastoma
11
Leukemia, Myelomonocytic, Chronic
11
Neoplasms, Plasma Cell
10
Myeloproliferative Disorders
10
Graft vs Host Disease
10
Lymphoma, Follicular
9
Leukemia, Biphenotypic, Acute
9
Burkitt Lymphoma
8
Neoplasms
7
Lymphoma, Mantle-Cell
7
Leukemia, Myelomonocytic, Juvenile
7
Breast Neoplasms
6
Rhabdoid Tumor
5
Recurrence
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, T-Cell
5
Lymphoma, B-Cell, Marginal Zone
5
Interventions
Lenalidomide
2
Dexamethasone
2
Bortezomib
2
ruxolitinib
1
posaconazole
1
darinaparsin
1
carfilzomib
1
belinostat
1
Stem Cell Transplantation
1
SCIO-469
1
Low-Level Light Therapy
1
Hydroxyurea
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Marrow Neoplasms
×
Stem Cell Transplantation
×
Clear all
NCT04217356
2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
90 enrolled